Navigation Links
$10,000 ISSAC Award for Innovation Presented to MIT PhD

LEXINGTON, Mass., July 21 /PRNewswire/ -- Heejin Lee, an MIT PhD and scientist, was awarded the prestigious 2009 IAI Award for his work on a silicone-based combination product recently launched by TARIS Biomedical.

The ISSAC Award for Innovation recognizes and promotes the achievements of biomedical scientists, designers, engineers and other researchers involved in the development of silicone-based combination products. Combination products are a new FDA defined category of implantable medical devices that release drugs into the body in a controlled manner. Combination products represent a new and rapidly expanding area of life-saving and life-enhancing technology.

The award-winning device is designed to function like a pump, using osmotic pressure to release drugs into the bladder. The size of the device, which is made with silicone and nickel alloy wire, is about that of a paper clip and shaped like a pretzel. The device is inserted in a short catheter-based procedure in a doctor's office. Once implanted, the system is designed to deliver drugs into the bladder for a specific period of time. The device is removed by conventional, non-surgical procedures after a few weeks. The technology is based on research performed by internationally renowned MIT scientists Michael Cima and Robert Langer.

Bladder diseases affect 50 million people in the U.S. alone, and delivering drugs to the bladder is tricky business. The current options include oral tablets, which must travel through the body to get to the bladder and can cause side effects in other organs. Some bladder diseases are treated with individual infusions or injections of a drug. But there are limits to how much of the drugs can be pumped into the body in one sitting, and patients typically must return to their doctor for each dose. A combination product delivers drugs directly to the bladder, in controlled amounts over a defined period of time, which represents a leap forward from the limitations of the current treatment options.

About TARIS Biomedical

TARIS Biomedical Inc. is a specialty pharmaceutical company with deep expertise in therapeutics and drug-delivery convergence products. For more information, visit .

About ISSAC Medical

ISSAC Medical is the world's premier manufacturer of silicone-based drug-eluting products and medical devices. The company provides a full range of services, including fabrication, assembly, packaging, and sterilization of silicone-based medical devices and device components. For more information, visit


ISSAC Award winner Heejin Lee is presented with a check for $10,000; Left to right: Cheryl Elkins (VP Taris), Heejin Lee, Christine Bunt (COO Taris), and Rob Grant (ISSAC Medical)


    Paul Mazelin, Marketing Director
    Specialty Silicone Fabricators

This release was issued through eReleases(TM). For more information, visit

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Win a $10,000 Education Fund for Your Miracle Child
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
4. Mirus Bio Awarded Grants & Contracts of Over $5 Million
5. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
6. ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems
7. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
8. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
9. Preclinical Research on Coronary Stent with CeloNova BioSciences Polyzene(R)- F Nanocoating Receives Award at CIRSE 2007
10. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
11. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
Post Your Comments:
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):